CellaVision AB
STO:CEVI
CellaVision AB
STO:CEVI
Price:
226 SEK
0.22%
Market Closed
Updated:
May 2, 2024
CellaVision AB
Cash from Operating Activities
|
CellaVision AB
Cash from Operating Activities Peer Comparison
Comparables:
EKTA B
GETI B
ARJO B
ELOS B
SEDANA
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
CellaVision AB
STO:CEVI
|
Cash from Operating Activities
kr196.4m
|
CAGR 3-Years
40%
|
CAGR 5-Years
22%
|
CAGR 10-Years
22%
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Cash from Operating Activities
kr2B
|
CAGR 3-Years
25%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Getinge AB
STO:GETI B
|
Cash from Operating Activities
kr3B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Cash from Operating Activities
kr2.1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Elos Medtech AB
STO:ELOS B
|
Cash from Operating Activities
kr108.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Sedana Medical AB (publ)
STO:SEDANA
|
Cash from Operating Activities
-kr38.1m
|
CAGR 3-Years
-69%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
See Also
What is CellaVision AB's Cash from Operating Activities?
Cash from Operating Activities
196.4m
SEK
196.4m
SEK
Based on the financial report for Dec 31, 2023, CellaVision AB's Cash from Operating Activities amounts to 196.4m SEK.
What is CellaVision AB's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
22%
22%
Over the last year, the Cash from Operating Activities growth was 43%. The average annual Cash from Operating Activities growth rates for CellaVision AB have been 40% over the past three years , 22% over the past five years , and 22% over the past ten years .
You don't have any saved screeners yet
